Halozyme Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2013-03-31 | $733k | 127k | 5.76 |
| 2012-12-31 | $961k | 143k | 6.71 |
| 2012-09-30 | $2.3M | 305k | 7.54 |
| 2012-06-30 | $5.9M | 669k | 8.86 |
| 2012-03-31 | $8.0M | 628k | 12.76 |
| 2011-12-31 | $6.3M | 662k | 9.51 |
| 2011-09-30 | $4.9M | 790k | 6.14 |
| 2011-06-30 | $5.3M | 768k | 6.91 |
| 2011-03-31 | $5.3M | 791k | 6.70 |
| 2010-12-31 | $5.4M | 676k | 7.92 |